Type to search

Albert Bourla

Share
Albert Bourla
Chairman and Chief Executive Officer

Albert Bourla

Posts Featuring Albert Bourla

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology | Pharmtech Focus

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron | Pharmtech Focus

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S. | Pharmtech Focus

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.

Pfizer Names David M. Denton Chief Financial Officer | Pharmtech Focus

Pfizer Names David M. Denton Chief Financial Officer

Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19 | Pharmtech Focus

Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19

Pfizer and Biontech Expand Collaboration with U.S. To Provide 500 Million Additional Covid-19 Vaccine Doses at Not-for-profit Price for Donation to Poorest Countries | Pharmtech Focus

Pfizer and Biontech Expand Collaboration with U.S. to Provide 500 Million Additional Covid-19 Vaccine Doses at Not-for-profit Price for Donation to Poorest Countries

Pfizer Announces New Chief Business Innovation Officer Aamir Malik | Pharmtech Focus

Pfizer Announces New Chief Business Innovation Officer Aamir Malik

Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older | Pharmtech Focus

Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older

Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of Covid-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S. | Pharmtech Focus

Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of Covid-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa | Pharmtech Focus

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa

Pfizer Announces New Investor Relations Leader | Pharmtech Focus

Pfizer Announces New Investor Relations Leader

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents | Pharmtech Focus

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

Pfizer and BioNTech Initiate BLA for FDA Approval of Vaccine | Pharmtech Focus

Pfizer and BioNTech Initiate BLA for FDA Approval of Vaccine

Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games | Pharmtech Focus

Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games

Pfizer and BionTech achieve first authorization in the world for a vaccine to combat Covid-19 | Pharmtech Focus

Pfizer and BionTech achieve first authorization in the world for a vaccine to combat Covid-19